Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Immunol Lett ; 167(2): 116-24, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26277554

RESUMO

Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a key glycolytic enzyme that is predominantly localized in the cytoplasm. However, recent studies have suggested that GAPDH is released by various cells and that extracellular GAPDH is involved in the regulation of neuritogenesis in neuronal cells. It has also been reported that GAPDH is expressed on the surfaces of macrophages and functions as a transferrin receptor. However, since GAPDH is a leaderless protein the mechanisms by which it reaches the extracellular environment remain unclear. Here, we examined the role of P2X7 receptor (P2X7R), an ATP-gated cation channel, in the unconventional release of GAPDH from microglial cells, the resident macrophages in the brain. The activation of P2X7R by ATP triggered GAPDH release from lipopolysaccharide (LPS)-primed microglial cells. ATP-induced microvesicle formation, exosome release, and K(+) efflux followed by caspase-1 activation are likely involved in the GAPDH release, but ATP-induced dilatation of membrane pores and lysosome exocytosis are not. It was also demonstrated that exogenous GAPDH facilitated LPS-induced phosphorylation of p38 MAP kinase in microglial cells. These findings suggest that P2X7R plays an important role in the unconventional release of GAPDH from microglial cells, and the GAPDH released into the extracellular space might be involved in the regulation of the neuroinflammatory response in the brain.


Assuntos
Trifosfato de Adenosina/metabolismo , Gliceraldeído-3-Fosfato Desidrogenases/metabolismo , Microglia/imunologia , Microglia/metabolismo , Caspase 1/metabolismo , Células Cultivadas , Ativação Enzimática , Ensaio de Imunoadsorção Enzimática , Exocitose/imunologia , Espaço Extracelular , Humanos , Imuno-Histoquímica , Lipopolissacarídeos/imunologia , Lisossomos/imunologia , Lisossomos/metabolismo , Fosforilação , Potássio/metabolismo , Cultura Primária de Células , Receptores Purinérgicos P2X7/metabolismo , Proteínas Quinases p38 Ativadas por Mitógeno/metabolismo
2.
Biochem Biophys Res Commun ; 418(1): 22-6, 2012 Feb 03.
Artigo em Inglês | MEDLINE | ID: mdl-22214931

RESUMO

In the previous studies, we reported that carnosic acid (CA) protects cortical neurons by activating the Keap1/Nrf2 pathway, which activation is initiated by S-alkylation of the critical cysteine thiol of the Keap1 protein by the "electrophilic"quinone-type CA. Here, we found that the pro-electrophilic CA inhibited the in vitro lipopolysaccharide (LPS)-induced activation of cells of the mouse microglial cell line MG6. LPS induced the expression of IL-1ß and IL-6, typical inflammatory cytokines released from microglial cells. CA inhibited the NO production associated with a decrease in the level of inducible NO synthase. Neither CA nor LPS affected cell survival at the concentrations used here. These actions of CA seemed to be mediated by induction of phase 2 genes (gclc, gclm, nqo1 and xct). We propose that an inducer of phase 2 genes may be a critical regulator of microglial activation. Thus, CA is a unique pro-electrophilic compound that provides both a protective effect on neurons and an anti-inflammatory one on microglia through induction of phase 2 genes.


Assuntos
Abietanos/farmacologia , Fase G2/efeitos dos fármacos , Microglia/efeitos dos fármacos , Microglia/imunologia , Extratos Vegetais/farmacologia , Sistema y+ de Transporte de Aminoácidos/genética , Animais , Linhagem Celular , Fase G2/genética , Glutamato-Cisteína Ligase/genética , Interleucina-1beta/antagonistas & inibidores , Interleucina-1beta/biossíntese , Interleucina-6/antagonistas & inibidores , Interleucina-6/biossíntese , Lipopolissacarídeos/imunologia , Camundongos , NAD(P)H Desidrogenase (Quinona)/genética , Óxido Nítrico/antagonistas & inibidores , Óxido Nítrico/biossíntese , Óxido Nítrico Sintase Tipo II/antagonistas & inibidores
3.
J Neurochem ; 117(4): 712-23, 2011 May.
Artigo em Inglês | MEDLINE | ID: mdl-21395581

RESUMO

The potent pro-inflammatory cytokine, interleukin-1ß (IL-1ß), is synthesized as an inactive 33-kDa precursor (pro-IL-1ß) and is processed by caspase 1 into the bioactive 17-kDa mature form. The P2X7 receptor, an ATP-gated cation channel, plays an essential role in caspase 1 activation, production and release of mature bioactive 17-kDa form. We recently reported ATP induces the release of an unconventional 20-kDa form of IL-1ß (p20-IL-1ß) from lipopolysaccharide-primed microglial cells. Emerging evidence suggests physiological relevance for p20-IL-1ß; however, the underlying mechanisms for its production and release remain unknown. Here, we investigated the pathways involved in the ATP-induced production of p20-IL-1ß using lipopolysaccharide-primed mouse microglial cells. The activation of P2X7 receptor by ATP triggered p20-IL-1ß production under acidic extracellular conditions. ATP-induced p20-IL-1ß production was blocked by pepstatin A, a potent inhibitor of the lysosomal protease, cathepsin D. The removal of extracellular Ca(2+) inhibited the p20-IL-1ß production as well as ATP-induced cathepsin D release via lysosome exocytosis. The acidic extracellular pH also facilitated the dilatation of membrane pore after ATP stimulation. Since facilitation of pore dilatation results in cytolysis accompanied with cytoplasmic pro-IL-1ß leakage, our data suggest the leaked pro-IL-1ß is processed into p20-IL-1ß by cathepsin D released after ATP stimulation under acidic extracellular conditions.


Assuntos
Catepsina D/farmacologia , Espaço Extracelular/metabolismo , Interleucina-1beta/biossíntese , Lipopolissacarídeos/farmacologia , Microglia/metabolismo , Receptores Purinérgicos P2X7/efeitos dos fármacos , Trifosfato de Adenosina/farmacologia , Animais , Western Blotting , Caspase 1/metabolismo , Linhagem Celular , Exocitose/efeitos dos fármacos , Concentração de Íons de Hidrogênio , Imuno-Histoquímica , Lisossomos/efeitos dos fármacos , Lisossomos/metabolismo , Camundongos , Camundongos Endogâmicos C57BL , Microglia/efeitos dos fármacos , Proteínas do Tecido Nervoso/biossíntese , Pepstatinas/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA